NEWS
06/09/2009
Sutro Biopharma Adds to Extensive IP Portfolio with Two Newly Issued Patents and Two Patent Grant Notices...
Sutro Biopharma Adds to Extensive IP Portfolio with Two Newly Issued Patents and Two Patent Grant Notices...
03/30/2009
Sutro Biopharma Hits Major Technical Milestone, Reaching 100 Liter Scale for the Company’s Open Cell-free Protein Synthesis Technology...
Sutro Biopharma Hits Major Technical Milestone, Reaching 100 Liter Scale for the Company’s Open Cell-free Protein Synthesis Technology...
01/12/2009
William J. Newell Named Chief Executive Officer of Sutro Biopharma. Former CEO Daniel S. Gold, Ph.D. Becomes President and Chief Operating Officer...
William J. Newell Named Chief Executive Officer of Sutro Biopharma. Former CEO Daniel S. Gold, Ph.D. Becomes President and Chief Operating Officer...
TRANSLATING SCIENCE
TO NOVEL BIOTHERAPEUTICS
TRANSLATING SCIENCE
TO NOVEL BIOTHERAPEUTICS
TO NOVEL BIOTHERAPEUTICS
Sutro Biopharma, Inc. is a biopharmaceutical company that uses its patented Open Cell Free Synthesis (OCFS) technology to develop next- generation protein therapeutics for the treatment of human disease.
| Site Map
Site Design: Schenkel/Stegman